TransEnterix Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
16,205.00
34,766.00
38,449.00
24,165.00
91,217.00
72,851
Total Accounts Receivable
256.00
134.00
618.00
1,976.00
3,038.00
8,595
Inventories
701.00
-
9,326.00
9,689.00
17,220.00
18,699
Other Current Assets
593.00
789.00
750.00
2,186.00
1,519.00
1,438
Total Current Assets
17,755.00
35,689.00
49,143.00
38,016.00
112,994.00
101,583
Net Property, Plant & Equipment
1,864.00
3,120.00
4,408.00
5,772.00
6,670.00
6,337
Total Investments and Advances
375.00
250.00
-
10,425.00
6,389.00
590
Long-Term Note Receivable
-
-
-
266.00
-
-
Intangible Assets
96,593.00
96,090.00
194,278.00
121,707.00
124,006.00
130,594
Other Assets
127.00
62.00
773.00
63.00
192.00
203
Total Assets
116,714.00
135,211.00
250,235.00
178,843.00
254,379.00
244,045
ST Debt & Current Portion LT Debt
3,879.00
610.00
6,727.00
7,997.00
4,788.00
Accounts Payable
1,804.00
1,768.00
4,450.00
3,984.00
3,771.00
Other Current Liabilities
1,406.00
1,769.00
19,895.00
18,708.00
20,281.00
Total Current Liabilities
7,089.00
4,147.00
31,072.00
30,689.00
28,840.00
Long-Term Debt
4,602.00
9,275.00
12,990.00
4,995.00
8,385.00
Provision for Risks & Charges
-
-
11,000.00
12,298.00
11,699.00
Deferred Taxes
-
-
16,263.00
10,397.00
8,389.00
Other Liabilities
-
-
-
-
14,090.00
Total Liabilities
11,691.00
13,422.00
72,958.00
60,973.00
75,531.00
Common Equity (Total)
105,023.00
121,789.00
177,277.00
117,870.00
178,848.00
Total Shareholders' Equity
105,023.00
121,789.00
177,277.00
117,870.00
178,848.00
Total Equity
105,023.00
121,789.00
177,277.00
117,870.00
178,848.00
Liabilities & Shareholders' Equity
116,714.00
135,211.00
250,235.00
178,843.00
254,379.00

About TransEnterix

View Profile
Address
635 Davis Drive
Morrisville North Carolina 27560
United States
Employees -
Website http://www.transenterix.com
Updated 07/08/2019
TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform.